Skip to main content
Clinical Trials/CTRI/2024/05/067239
CTRI/2024/05/067239
Not yet recruiting
Phase 3

Effect of topical recombinant human epidermal growth factor on chronic diabetic ulcer compared with conventional saline dressing - Randomized controlled trial - NI

Dr A Sneha Daffodil0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr A Sneha Daffodil
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr A Sneha Daffodil

Eligibility Criteria

Inclusion Criteria

  • Grade 1 and 2 wagners classification
  • ulcer duration more than 3 weeks
  • able to understand the merits and demerits of both the procedure and provide consent

Exclusion Criteria

  • Age less than 18 years and more than 80 years 2\.Patient with cardiac disease,HIV,Hepatitis, pregnancy and critically ill patients 3\.Chronic venous/Aretrial ulcers 4\.Malignant ulcers 5\.Anemia( \<7gm/dl) 6\.Known or Suspected osteomyelitis 7\.Ulcer is less than 2cm.

Outcomes

Primary Outcomes

Not specified

Similar Trials